Aims & Scope

Aims:  

Medicinal Chemistry Advances (MCA) is a gold open-access, peer-reviewed journal dedicated to serving as a premier global platform for disseminating cutting-edge research at the intersection of medicinal chemistry, drug discovery, and translational medicine. As a flagship journal published quarterly online by Scilight Press, MCA aims to bridge fundamental science and clinical practice, fostering interdisciplinary collaboration among medicinal chemists, structural biologists, pharmacologists, clinicians, and data scientists.  

The journal is committed to advancing the field of medicinal chemistry by publishing high-quality, innovative research that addresses unmet clinical needs, tackles critical scientific challenges (e.g., drug resistance, poor druggability, and complex disease pathogenesis), and accelerates the translation of chemical biology insights into novel therapeutic agents. MCA seeks to highlight breakthroughs in rational drug design, target validation, and lead optimization, ultimately contributing to the development of safer, more effective therapies for major human diseases.

Scope:

Medicinal Chemistry Advances encompasses a broad spectrum of topics in medicinal chemistry and drug discovery, with a focus on innovative strategies, technologies, and translational applications. The scope includes but is not limited to:  

  • Molecular Targets and Mechanisms

Structure-based and ligand-based drug design targeting disease-relevant proteins, including enzymes (e.g., proteases, kinases, nucleases), receptors (GPCRs, nuclear receptors), ion channels, and protein-protein interactions.  

Mechanistic insights into target validation, druggability assessment, and target vulnerability, integrating structural biology (X-ray crystallography, cryo-EM), biophysics, and functional genomics.  

Exploration of emerging targets in infectious diseases (viral, bacterial, fungal), cancer, metabolic disorders (diabetes, obesity), neurodegenerative diseases, and autoimmune disorders.  

  • Medicinal Chemistry Strategies and Technologies

Rational lead optimization using advanced chemical biology approaches, including fragment-based drug discovery, scaffold hopping, and multi-target drug design.  

Application of computational tools in medicinal chemistry: artificial intelligence/machine learning (AI/ML)-guided drug design, molecular docking, molecular dynamics simulations, and virtual screening.  

Chemical proteomics and chemogenomics for target deconvolution, polypharmacology studies, and identification of off-target effects.  

Innovative synthetic chemistry strategies: click chemistry, multicomponent reactions, and modular synthesis for library construction and lead diversification.

  • Therapeutic Areas and Disease-Focused Research  

Antiviral medicinal chemistry: discovery of inhibitors against emerging and re-emerging viruses (e.g., SARS-CoV-2, influenza, HIV, HBV), with emphasis on overcoming viral resistance and improving broad-spectrum activity.  

Anticancer agents: targeted therapies against oncogenic drivers (e.g., kinase mutations, epigenetic regulators), PROTACs (proteolysis-targeting chimeras), and drug repurposing for cancer treatment.

Metabolic disease therapeutics: modulators of metabolic pathways, gut microbiota-related targets, and agents targeting obesity and its comorbidities.

Neurotherapeutics: small molecules for neurodegenerative diseases (Alzheimer’s, Parkinson’s) and neuropsychiatric disorders, focusing on blood-brain barrier penetration and target selectivity.  

  • Emerging Paradigms and Translational Aspects  

Novel drug modalities: peptidomimetics, boron-containing compounds, sulfonyl fluorides, and other privileged scaffolds with improved pharmacokinetic/pharmacodynamic (PK/PD) profiles.  

Strategies to address drug resistance: structural insights into resistance mechanisms, design of next-generation inhibitors, and combination therapies.  

Translational medicinal chemistry: ADMET (absorption, distribution, metabolism, excretion, toxicity) optimization, prodrug design, and early-phase clinical candidate development.  

Integration of multi-omics data (genomics, metabolomics, transcriptomics) with medicinal chemistry for precision medicine and personalized therapy design.

By encompassing these areas, Medicinal Chemistry Advances aims to drive innovation in drug discovery, facilitate knowledge exchange across disciplines, and inspire the development of transformative therapeutic solutions to global health challenges.